Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | BRD-K33514849 | CTRPv2 | pan-cancer | AAC | 0.053 | 0.7 |
mRNA | Bryostatin 1 | GDSC1000 | pan-cancer | AAC | -0.016 | 0.7 |
mRNA | compound 1B | CTRPv2 | pan-cancer | AAC | 0.017 | 0.7 |
mRNA | CHIR-99021 | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
mRNA | ruxolitinib | GDSC1000 | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | Erlotinib | CCLE | pan-cancer | AAC | 0.02 | 0.7 |
mRNA | N9-isopropylolomoucine | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | KIN001-266 | GDSC1000 | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | QL-XII-47 | GDSC1000 | pan-cancer | AAC | -0.014 | 0.7 |
mRNA | Rapamycin | gCSI | pan-cancer | AAC | -0.023 | 0.7 |